HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | Cardiogen |
|---|---|
| Molecular formula | C18H31N7O9 |
| Molecular weight | 489.5 g/mol |
| Sequence | Ala-Glu-Asp-Arg |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 5mg / 10mg |
| Documentation | Batch-linked COA + HPLC chromatogram + MS identity record for every production lot |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder at -20°C for long-term stability; brief room-temperature exposure during shipping and handling is tolerated. After reconstitution, hold at 2-8°C and use within the validated window. Protect from light and moisture and avoid repeated freeze-thaw cycles. |
| Tier | Quantity | Lead time |
|---|---|---|
| OEM lot | 50 kits (500 vials) | 3–7 days |
| Production lot | 500–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Supplied as a research-use peptide. Every quote confirms current-batch COA, purity, destination market and buyer track before invoicing.
Overview
Cardiogen is a short synthetic tetrapeptide (Ala-Glu-Asp-Arg) from the Khavinson family of tissue-specific peptide bioregulators, studied in preclinical cardiomyocyte and fibroblast cultures for the AEDR sequence's proposed influence on cardiac-related gene expression and structural-protein markers. It is supplied strictly as a research-use material and has no approved therapeutic application in any jurisdiction.
Documentation
batch-linked COA, HPLC chromatogram and MS identity record for every production lot. Distribution scope confirmed before invoicing.
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Mass spectrometry identity confirmation against the Cardiogen reference profile.
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
Cardiogen is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Arg (AEDR), part of the Khavinson family of short tissue-specific peptide bioregulators. It is offered strictly as a research-use material for laboratory and in vitro work.
Cardiogen is supplied as lyophilized powder in 5mg and 10mg vials, with a minimum order quantity of 50 kits (500 vials). Custom fill weights and bulk peptide quantities are available on RFQ.
Every production lot includes a batch-linked COA showing HPLC purity and mass-spectrometry (MS) identity confirmation. Additional data such as residual-solvent, appearance, or endotoxin (only if specifically ordered and tested) results can be provided on request for qualifying programs.
Cardiogen (Ala-Glu-Asp-Arg) has no widely assigned CAS registry number. It is catalogued in PubChem as CID 11583989 with molecular formula C18H31N7O9; identity is confirmed per lot by mass spectrometry rather than by CAS lookup, and any specific values are confirmed on the COA at RFQ.
Yes. We manufacture Cardiogen for private-label and OEM buyers, including custom labeling, vial configuration, and bulk supply. Export and compliance documentation for your destination market can be prepared on request.
Related compounds